パニック障害の世界市場レポート 2025年

パニック障害市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は5.7％で、139億6,000万米ドルに成長します。予測期間の成長は、新たな薬理学的治療、遠隔精神医療サービス、併存疾患への注目、世界のメンタルヘルス・イニシアチブ、治療における薬理ゲノミクス、公教育プログラムなどに起因すると考えられます。予測期間の主な動向には、デジタルメンタルヘルス介入、パニック障害治療のための遠隔医療、薬物療法の革新、神経生物学的研究、遠隔モニタリング、ウェアラブル技術などが含まれます。

精神科患者の急増は、予見可能な将来におけるパニック障害市場の拡大を推進する構えです。認知的、感情的、社会的機能のさまざまな側面を混乱させる精神衛生状態に罹患している精神科患者は、突然の激しい不安エピソードを特徴とするパニック障害に罹患しやすいです。精神疾患の治療には、パニック発作の症状を和らげ、全体的な幸福感を高め、効果的な対処法を養うために、治療、薬物療法、生活習慣の改善を組み合わせた多面的なアプローチがしばしば用いられます。例えば、Mental Health Americaによる「State of Mental Health in America 2022」報告書では、2021年には米国総人口の19.00%を占める47,132,000人であったのに対し、2022年には米国総人口の19.86%を占める49,564,000人となり、精神科患者の増加が指摘されています。したがって、精神科患者数の増加がパニック障害市場の成長を牽引することになります。

テレヘルスの利用拡大がパニック障害市場を大きく押し上げると予想されます。テレビ会議、電話、セキュア・メッセージングなどの電子通信手段を含むテレヘルスは、パニック障害に悩む人々のための心理療法やカウンセリングを含む遠隔診察やヘルスケアサービスを可能にします。この技術により、患者は直接訪問することなく、メンタルヘルス・サービスを受けやすくなり、アクセシビリティと利便性が向上します。例えば、2023年4月にFAIR Health Inc.が発表したレポートでは、テレヘルスの利用が7.3%増加し、2022年12月の5.5%から2023年1月には医療請求ラインの5.9%に上昇することが明らかになりました。遠隔医療が成長し続けるにつれて、パニック障害市場への影響は、効果的な治療オプションや遠隔治療サービスの需要を促進すると予想されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界パニック障害 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のパニック障害市場：成長率分析
• 世界のパニック障害市場の実績：規模と成長, 2019-2024
• 世界のパニック障害市場の予測：規模と成長, 2024-2029, 2034F
• 世界パニック障害総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のパニック障害市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 広場恐怖症
• 社会不安障害（SAD）
• 強迫性障害（OCD）
• 双極性障害
• 心的外傷後ストレス障害（PTSD）
• 大うつ病性障害
• 世界のパニック障害市場治療別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 薬
• ベータ遮断薬
• セロトニン・ノルエピネフリン再取り込み阻害剤（SNRI）
• ベンゾジアゼピン
• 抗てんかん
• その他の治療法
• 世界のパニック障害市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• 非経口
• その他の投与経路
• 世界のパニック障害市場：最終用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界のパニック障害市場広場恐怖症の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 状況的広場恐怖症
• 非状況的広場恐怖症
• 世界のパニック障害市場、社会不安障害（SAD）のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• パフォーマンス不安
• 全般性社会不安
• 世界のパニック障害市場強迫性障害（OCD）のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 汚染強迫性障害
• 害悪強迫性障害
• OCDのチェック
• 対称性強迫性障害
• 世界のパニック障害市場、双極性障害のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 双極性障害I型
• 双極性障害 II
• 気分循環性障害
• 世界のパニック障害市場、心的外傷後ストレス障害（PTSD）のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 急性PTSD
• 慢性PTSD
• 複雑性PTSD
• 世界のパニック障害市場、大うつ病性障害のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 再発性大うつ病
• 単発性大うつ病性障害

第7章 地域別・国別分析

• 世界のパニック障害市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のパニック障害市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• パニック障害市場：競合情勢
• パニック障害市場：企業プロファイル
  • F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A Overview, Products and Services, Strategy and Financial Analysis
  • Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• GlaxoSmithKline plc
• Eli Lilly and Company
• Boehringer Ingelheim International GmbH.
• Baxter Inc
• Teva Pharmaceutical Industries Ltd
• Mylan N.V.
• Pfizer Inc.
• Sun Pharmaceutical Industries Ltd
• Bausch Health Companies Inc.
• H. Lundbeck A/S
• Shionogi & Co Ltd.
• Recordati S.p.A
• Neurocrine Biosciences Inc
• Neuraxpharm
• Actavis Plc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• パニック障害市場2029：新たな機会を提供する国
• パニック障害市場2029：新たな機会を提供するセグメント
• パニック障害市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Panic disorder is a specific type of anxiety condition characterized by unexpected and recurring episodes of intense anxiety accompanied by physical symptoms such as shortness of breath, chest pain, heart palpitations, nausea, and abdominal discomfort. Treatment for panic disorder typically involves a combination of medication and psychotherapy.

The main subtypes of panic disorders include agoraphobia, social anxiety disorder (SAD), obsessive-compulsive disorder (OCS), bipolar disorder, post-traumatic stress disorder (PTSD), and major depressive disorder. Agoraphobia involves the intentional avoidance of places or situations that may trigger panic symptoms, leading to feelings of confinement, helplessness, or social discomfort. Various treatment options include medication, beta-blockers, serotonin and norepinephrine reuptake inhibitors (SNRIs), benzodiazepines, anti-epilepsy medications, and others, which can be administered orally, through injections, and other methods. These treatments are available through hospital pharmacies, retail pharmacies, and online pharmacy stores.

The panic disorders market research report is one of a series of new reports from The Business Research Company that provides panic disorders market statistics, including panic disorders industry global market size, regional shares, competitors with a panic disorders market share, detailed panic disorders market segments, market trends and opportunities, and any further data you may need to thrive in the panic disorders industry. This panic disorders market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The panic disorders market size has grown steadily in recent years. It will grow from $10.73 billion in 2024 to $11.19 billion in 2025 at a compound annual growth rate (CAGR) of 4.3%. The growth in the historic period can be attributed to antidepressant medications, increased mental health awareness, increased stress levels, access to mental health services, advancements in diagnostic criteria.

The panic disorders market size is expected to see strong growth in the next few years. It will grow to $13.96 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to emerging pharmacological treatments, telepsychiatry services, focus on comorbidities, global mental health initiatives, pharmacogenomics in treatment, public education programs. Major trends in the forecast period include digital mental health interventions, telemedicine for panic disorder treatment, innovations in medications, neurobiological research, remote monitoring and wearable technology.

An upsurge in the population of psychiatric patients is poised to propel the expansion of the panic disorder market in the foreseeable future. Psychiatric patients, affected by mental health conditions that disrupt various aspects of their cognitive, emotional, and social functioning, are susceptible to panic disorder, characterized by sudden and intense episodes of anxiety. Treatment for individuals dealing with psychiatric conditions often involves a multifaceted approach combining therapy, medication, and lifestyle modifications to alleviate panic attack symptoms, enhance overall well-being, and foster effective coping mechanisms. For instance, the State of Mental Health in America 2022 report by Mental Health America noted an increase in psychiatric patients, reaching 49,564,000 individuals, constituting 19.86% of the total US population in 2022, compared to 47,132,000 individuals, comprising 19.00% of the total US population in 2021. Hence, the rise in psychiatric patient numbers is set to drive the growth of the panic disorder market.

The growing use of telehealth is expected to significantly boost the panic disorders market. Telehealth, which involves electronic communication methods like videoconferencing, phone calls, and secure messaging, enables remote consultations and healthcare services, including psychotherapy and counseling for individuals suffering from panic disorders. This technology makes it easier for patients to access mental health services without the need for in-person visits, improving accessibility and convenience. For example, a report from FAIR Health Inc. in April 2023 revealed a 7.3% increase in telehealth usage, rising from 5.5% in December 2022 to 5.9% of medical claim lines in January 2023. As telehealth continues to grow, its impact on the panic disorders market is expected to drive demand for effective treatment options and remote therapeutic services.

Key companies engaged in the panic disorder market are concentrating on the development of advanced medications, notably extended-release capsules, to fortify their foothold in the market. Extended-release capsules are medications designed to gradually release the active ingredients over an extended period, typically 12 or 24 hours, suitable for managing conditions requiring prolonged medication. As an example, in May 2023, Granules India Ltd., an Indian pharmaceutical company, obtained abbreviated new drug application (ANDA) approval from the US Food & Drug Administration (USFDA) for Venlafaxine hydrochloride extended-release capsules. These capsules have demonstrated bioequivalence with the reference-listed drug product (RLD), Effexor XR Extended-Release Capsules, manufactured by Upjohn US 2 LLC. Venlafaxine HCl extended-release capsules are prescribed to manage various conditions such as generalized anxiety disorder (GAD), major depressive disorder (MDD), panic disorder (PD), and social anxiety disorder (SAD). They operate by increasing serotonin and norepinephrine levels in the brain, usually starting at a dosage of 75 mg per day and adjusted as required under a doctor's supervision.

In February 2023, Vistagen Therapeutics Inc., a clinical-stage biopharmaceutical company based in the United States, successfully acquired Pherin Pharmaceuticals Inc. for an undisclosed sum. This strategic acquisition positions Vistagen to advance and bring to market innovative treatments designed for individuals dealing with depression and anxiety disorders. The collaboration is anticipated to enhance the commercial prospects of each drug candidate, strengthening Vistagen's portfolio in addressing mental health challenges. Pherin Pharmaceuticals Inc., the acquired company, specializes in drug development focused on panic disorders.

Major companies operating in the panic disorders market report are F. Hoffmann-La Roche Ltd., Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Eli Lilly and Company, Boehringer Ingelheim International GmbH., Baxter Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Bausch Health Companies Inc., H. Lundbeck A/S, Shionogi & Co Ltd., Recordati S.p.A, Neurocrine Biosciences Inc., Neuraxpharm, Actavis Plc., Noven Pharmaceuticals Inc., Sumitomo Pharma Co. Ltd., VistaGen Therapeutics, Valeant Pharmaceuticals International Inc., LIFECARE NEURO PRODUCTS LTD.

North America was the largest region in the panic disorders market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the panic disorders market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the panic disorders market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The panic disorder market consists of revenue earned by entities by providing services such as physical tests, cognitive behavioral therapy (CBT), and psychological evaluation. The market value includes the value of related goods sold by the service provider or included within the service offering. The panic disorder market includes sales of tablets and injectables. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Panic Disorders Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on panic disorders market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for panic disorders ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The panic disorders market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Agoraphobia; Social Anxiety Disorder (SAD); Obsessive-Compulsive Disorder (OCD); Bipolar Disorder; Post-Traumatic Stress Disorder (PTSD); Major Depressive Disorder
• 2) By Treatment: Medication; Beta Blockers; Serotonin And Norepinephrine Reuptake Inhibitors (SNRIs); Benzodiazepines; Anti-Epilepsy; Other Treatments
• 3) By Route Of Administration: Oral; Parenteral; Other Routes Of Administrations
• 4) By End Use: Hospital Pharmacies; Retailer Pharmacies; Online Pharmacy Stores
• Subsegments:
• 1) By Agoraphobia: Situational Agoraphobia; Non-Situational Agoraphobia
• 2) By Social Anxiety Disorder (SAD): Performance Anxiety; Generalized Social Anxiety
• 3) By Obsessive-Compulsive Disorder (OCD): Contamination OCD; Harm OCD; Checking OCD; Symmetry OCD
• 4) By Bipolar Disorder: Bipolar I Disorder; Bipolar II Disorder; Cyclothymic Disorder
• 5) By Post-Traumatic Stress Disorder (PTSD): Acute PTSD; Chronic PTSD; Complex PTSD
• 6) By Major Depressive Disorder: Recurrent Major Depressive Disorder; Single Episode Major Depressive Disorder
• Companies Mentioned: F. Hoffmann-La Roche Ltd; Sanofi S.A; Bristol-Myers Squibb Company; AstraZeneca plc; Abbott Laboratories
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Panic Disorders Market Characteristics

3. Panic Disorders Market Trends And Strategies

4. Panic Disorders Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Panic Disorders Growth Analysis And Strategic Analysis Framework

• 5.1. Global Panic Disorders PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Panic Disorders Market Growth Rate Analysis
• 5.4. Global Panic Disorders Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Panic Disorders Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Panic Disorders Total Addressable Market (TAM)

6. Panic Disorders Market Segmentation

• 6.1. Global Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Agoraphobia
• Social Anxiety Disorder (SAD)
• Obsessive-Compulsive Disorder (OCD)
• Bipolar Disorder
• Post-Traumatic Stress Disorder (PTSD)
• Major Depressive Disorder
• 6.2. Global Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medication
• Beta Blockers
• Serotonin And Norepinephrine Reuptake Inhibitors (SNRIs)
• Benzodiazepines
• Anti-Epilepsy
• Other Treatments
• 6.3. Global Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Parenteral
• Other Routes Of Administrations
• 6.4. Global Panic Disorders Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retailer Pharmacies
• Online Pharmacy Stores
• 6.5. Global Panic Disorders Market, Sub-Segmentation Of Agoraphobia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Situational Agoraphobia
• Non-Situational Agoraphobia
• 6.6. Global Panic Disorders Market, Sub-Segmentation Of Social Anxiety Disorder (SAD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Performance Anxiety
• Generalized Social Anxiety
• 6.7. Global Panic Disorders Market, Sub-Segmentation Of Obsessive-Compulsive Disorder (OCD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Contamination OCD
• Harm OCD
• Checking OCD
• Symmetry OCD
• 6.8. Global Panic Disorders Market, Sub-Segmentation Of Bipolar Disorder, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bipolar I Disorder
• Bipolar II Disorder
• Cyclothymic Disorder
• 6.9. Global Panic Disorders Market, Sub-Segmentation Of Post-Traumatic Stress Disorder (PTSD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acute PTSD
• Chronic PTSD
• Complex PTSD
• 6.10. Global Panic Disorders Market, Sub-Segmentation Of Major Depressive Disorder, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Recurrent Major Depressive Disorder
• Single Episode Major Depressive Disorder

7. Panic Disorders Market Regional And Country Analysis

• 7.1. Global Panic Disorders Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Panic Disorders Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Panic Disorders Market

• 8.1. Asia-Pacific Panic Disorders Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Panic Disorders Market

• 9.1. China Panic Disorders Market Overview
• 9.2. China Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Panic Disorders Market

• 10.1. India Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Panic Disorders Market

• 11.1. Japan Panic Disorders Market Overview
• 11.2. Japan Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Panic Disorders Market

• 12.1. Australia Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Panic Disorders Market

• 13.1. Indonesia Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Panic Disorders Market

• 14.1. South Korea Panic Disorders Market Overview
• 14.2. South Korea Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Panic Disorders Market

• 15.1. Western Europe Panic Disorders Market Overview
• 15.2. Western Europe Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Panic Disorders Market

• 16.1. UK Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Panic Disorders Market

• 17.1. Germany Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Panic Disorders Market

• 18.1. France Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Panic Disorders Market

• 19.1. Italy Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Panic Disorders Market

• 20.1. Spain Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Panic Disorders Market

• 21.1. Eastern Europe Panic Disorders Market Overview
• 21.2. Eastern Europe Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Panic Disorders Market

• 22.1. Russia Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Panic Disorders Market

• 23.1. North America Panic Disorders Market Overview
• 23.2. North America Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Panic Disorders Market

• 24.1. USA Panic Disorders Market Overview
• 24.2. USA Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Panic Disorders Market

• 25.1. Canada Panic Disorders Market Overview
• 25.2. Canada Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Panic Disorders Market

• 26.1. South America Panic Disorders Market Overview
• 26.2. South America Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Panic Disorders Market

• 27.1. Brazil Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Panic Disorders Market

• 28.1. Middle East Panic Disorders Market Overview
• 28.2. Middle East Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Panic Disorders Market

• 29.1. Africa Panic Disorders Market Overview
• 29.2. Africa Panic Disorders Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Panic Disorders Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Panic Disorders Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Panic Disorders Market Competitive Landscape And Company Profiles

• 30.1. Panic Disorders Market Competitive Landscape
• 30.2. Panic Disorders Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sanofi S.A Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

31. Panic Disorders Market Other Major And Innovative Companies

• 31.1. GlaxoSmithKline plc
• 31.2. Eli Lilly and Company
• 31.3. Boehringer Ingelheim International GmbH.
• 31.4. Baxter Inc
• 31.5. Teva Pharmaceutical Industries Ltd
• 31.6. Mylan N.V.
• 31.7. Pfizer Inc.
• 31.8. Sun Pharmaceutical Industries Ltd
• 31.9. Bausch Health Companies Inc.
• 31.10. H. Lundbeck A/S
• 31.11. Shionogi & Co Ltd.
• 31.12. Recordati S.p.A
• 31.13. Neurocrine Biosciences Inc
• 31.14. Neuraxpharm
• 31.15. Actavis Plc.

32. Global Panic Disorders Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Panic Disorders Market

34. Recent Developments In The Panic Disorders Market

35. Panic Disorders Market High Potential Countries, Segments and Strategies

• 35.1 Panic Disorders Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Panic Disorders Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Panic Disorders Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer